Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma

Clinical trial NCT02327390 · TERMINATED

Trial details

NCT number: NCT02327390
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IIIC Skin Melanoma Stage IV Melanoma

Start date: 2015-03-17
Primary completion: 2016-07-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.